Multilevel Peer-to-Peer HPV Vaccination and Wellness Educational Program in School Based Health Centers
PEER
2 other identifiers
interventional
4,000
1 country
1
Brief Summary
School-based health centers (SBHCs) are an important setting to improve health through detecting, managing and preventing chronic illness. Too few people are educated about the human papillomavirus (HPV), which can prevent tens of thousands of deaths from cancer each year. PEER will evaluate a program to increase health and wellness and the use of SBHCs for primary and preventive care. If successful, PEER could significantly increase the use of SBHCs, and decrease HPV-associated cancers and, thus, reduce the burden of cancer in the United States.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 12, 2026
CompletedFirst Submitted
Initial submission to the registry
February 6, 2026
CompletedFirst Posted
Study publicly available on registry
February 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2029
May 1, 2026
April 1, 2026
2.6 years
February 6, 2026
April 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of Vaccination for HPV (n of patients with HPV vaccination/n of patients eligible for vaccination)
Vaccination among eligible clinic patients, and time to vaccination
6 and 12 months
Secondary Outcomes (3)
Rates of new patients to the clinic (n of new patients/n of established patients)
6 and 12 months
Rate of use of other SBHC services (primary care visits, wellness assessments) (n of patients with primary care visits/n of new and established patients)
6 and 12 months
Rate of vaccination for other adolescent vaccinations (COVID-19, flu, Meningitis, or uptick of other vax's (TDAP, MMR, etc.)) (n of patients with additional vaccination among new and eligible clinic patients)
6 and 12 months
Study Arms (2)
Control time (pre-implementation)
NO INTERVENTIONAll participating SBHCs offer routine HPV vaccination recommendations as part of clinical care and SBHC staff will continue to follow standard procedures to deliver these services. Further, all SBHCs have existing relationships with the affiliated schools, so the delivery of these healthcare services in the context of schools will not deviate from usual care.
Intervention (post-implementation)
EXPERIMENTALIntervention components (mailers, provider materials, and peer-to-peer educational sessions) will be administered during the intervention portion of each cluster.
Interventions
Letter and fact sheet (infographic) mailed to caregivers of 9-14 year-olds and to teens 15-18, with optional phone call for "confidential patients" aged 15-18.
Clinic team/staff training based on qualitative interviews, recommended strategies and evidence-based interventions. Training materials include FAQs and Smart phrases. FAQs and informational sheets containing the same content as the mailers distributed in clinic to teen SBHC patients and their caregivers.
Educational sessions delivered in schools by OSBHA interns. Session content includes SBHC information and HPV awareness.
Eligibility Criteria
You may qualify if:
- Aged 9-18
- New or established patients
- Flagged if due for an HPV vaccine
You may not qualify if:
- \- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaiser Permanente Center for Health Research
Portland, Oregon, 97227, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Amanda Petrik, PhD
Kaiser Permanente
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2026
First Posted
February 17, 2026
Study Start
January 12, 2026
Primary Completion (Estimated)
August 1, 2028
Study Completion (Estimated)
June 1, 2029
Last Updated
May 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Deidentified data and accompanying data dictionaries will be stored for future sharing as anonymized data sets in a data repository per NIH data sharing requirements.